These breast cancers are called either luminal A or B subtype and they have relatively good prognosis compared to the more aggressive ERα-negative subtypes; HER2-enriched (HER2 + , ERα-) and triple-negative/basal-like (TNBC) breast cancer2,3. This evidence concerns the gene ESR1 and breast cancer.